| Literature DB >> 29593038 |
Wei Wang1, Hyo Sook Song2, Paul W Keller2, Esmeralda Alvarado-Facundo2, Russell Vassell2, Carol D Weiss1.
Abstract
Vaccines that elicit broadly neutralizing antibodies to the conserved stem of hemagglutinin (HA) are being developed as universal influenza vaccines that protect against influenza across multiple years. However, different influenza virus strains, even those in the same subtype with identical stem sequences, can vary in susceptibility to broadly neutralizing stem antibodies, and the reasons are not understood. Here we studied potential mechanisms underlying the differing sensitivities of a panel of H5N1 HA pseudoviruses to broadly neutralizing stem antibodies. We found that greater HA conformational stability, as measured by thermal inactivation and pH triggering of conformational changes, correlates with reduced neutralization sensitivity and antibody binding to HA under neutral- and low-pH conditions. Our data indicate that the conformational stability of HA is an important attribute of susceptibility to broadly neutralizing stem antibodies and is influenced by residues outside the stem antibody epitopes.IMPORTANCE The influenza virus surface glycoprotein hemagglutinin (HA) mediates virus attachment and membrane fusion between virus and host cells, allowing the viral core to enter the host cell cytoplasm for replication. Fusion occurs when HA undergoes low-pH-induced-conformational changes during endocytosis. Broadly neutralizing antibodies targeted to the conserved stem region of HA interfere with conformational changes required for fusion. Vaccines that elicit such antibodies are being developed as novel universal influenza vaccines for multiyear protection. We investigated why H5N1 HAs from different strains differ in their sensitivity to broadly neutralizing stem antibodies despite having conserved epitopes. We report that HA conformational stability due to residues outside the antibody binding site accounted for much of the variation in susceptibility to neutralization by stem antibodies. These findings highlight the importance of nonepitope residues in influencing neutralization sensitivity to stem antibodies and the complexities in developing universal vaccines targeting conserved epitopes in the HA stem.Entities:
Keywords: hemagglutinin stability; influenza hemagglutinin; influenza neutralization; stalk antibodies; stem antibodies; universal influenza vaccine
Mesh:
Substances:
Year: 2018 PMID: 29593038 PMCID: PMC5974491 DOI: 10.1128/JVI.00247-18
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103
H5 virus sensitivity to stem antibodies
| Clade | Virus strain | Stem antibody neutralization titer (μg/ml) | ||
|---|---|---|---|---|
| C179 | CR6261 | FI6-V3 | ||
| 0 | A/Hong Kong/156/1997 (HK/156) | 3.74 | 2.59 | 2.98 |
| 1 | A/Viet Nam/1203/2004 (VN/1203) | 0.09 | 0.06 | 0.11 |
| 1.1 | A/Cambodia/R0405050/2007 (CB/R0405050) | >20 | 14.02 | 11.39 |
| 2.1.3.2 | A/Indonesia/5/2005 (ID/5) | 0.51 | 0.11 | 0.21 |
| 2.2.1 | A/turkey/Turkey/1/2005 (TK/1) | >20 | 6.65 | 12.94 |
| 2.3.2.1 | A/gray heron/Hong Kong/3088/2007 (HK/3088) | >20 | >20 | >20 |
| 2.3.4 | A/Anhui/1/2005 (AH/1) | 0.82 | 0.31 | 0.36 |
| 2.4 | A/duck/Guangxi/13/2004 (GX/13) | >20 | 5.02 | 6.16 |
| 2.5 | A/crow/Osaka/102/2004 (OS/102) | >20 | 5.66 | 6.22 |
| 3 | A/duck/Hong Kong/2986.1/2000 (HK/2986.1) | >20 | 3.88 | 6.11 |
| 4 | A/goose/Guiyang/337/2006 (GY/337) | >20 | >20 | >20 |
| 5 | A/duck/Guangxi/1378/2004 (GX/1378) | 10.69 | 2.66 | 3.46 |
| 6 | A/duck/Hubei/wg/2002 (HB/wg) | 3.84 | 1.58 | 1.53 |
| 7.1 | A/chicken/Vietnam/NCVD-016/2008 (VN/NCVD-016) | 1.45 | 0.55 | 0.74 |
| 8 | A/chicken/Hong Kong/86.3/2002 (HK/86.3) | 8.44 | 1.1 | 1.58 |
| 9 | A/chukar/Shantou/4690/2003 (ST/4690) | >20 | >20 | >20 |
FIG 1Stem antibody epitopes and sequences of different H5 HAs. (A) Stem antibody epitopes are conserved among different H5 HAs. (B) Residues in VN/1203 HA that differ from those in HA of at least two strains among CB/R0405050, GY/337, and ST/4690. (C) Stem antibody epitopes and different residues (shown in panel B) in VN/1203 HA trimer (PDB entry 2FK0). In panels A and C, the epitopes are indicated as follows: green, C179 epitopes; yellow, CR6261 epitopes; pink, FI6 epitopes. In panel C, the epitopes and residues are indicated as follows: blue, C179 and CR6261 overlap epitopes; cyan, CR6261 and FI6 overlap epitopes; sienna, residue 419 (HA2 number 89); black, different residues on HA1 shown in panel B. HK/156, A/Hong Kong/156/1997; VN/1203, A/Viet Nam/1203/2004; CB/R0405050, A/Cambodia/R0405050/2007; ID/5, A/Indonesia/5/2005; TK/1, A/turkey/Turkey/1/2005; HK/3088, A/gray heron/Hong Kong/3088/2007; AH/1, A/Anhui/1/2005; GX/13, A/duck/Guangxi/13/2004; OS/102, A/crow/Osaka/102/2004; HK/2986.1, A/duck/Hong Kong/2986.1/2000; GY/337, A/goose/Guiyang/337/2006; GX/1378, A/duck/Guangxi/1378/2004; HB/wg, A/duck/Hubei/wg/2002; VN/NCVD-016, A/chicken/Vietnam/NCVD-016/2008; HK/86.3, A/chicken/Hong Kong/86.3/2002; ST/4690, A/chukar/Shantou/4690/2003.
ELISA endpoint titers of CR6261
| Virus | ELISA endpoint titer (μg/ml) |
|---|---|
| A/Hong Kong/156/1997 (HK/156) | 0.06250 |
| A/Viet Nam/1203/2004 (VN/1203) | 0.03125 |
| A/Cambodia/R0405050/2007 (CB/R0405050) | 0.25000 |
| A/Indonesia/5/2005 (ID/5) | 0.03125 |
| A/turkey/Turkey/1/2005 (TK/1) | 0.12500 |
| A/gray heron/Hong Kong/3088/2007 (HK/3088) | 0.25000 |
| A/Anhui/1/2005 (AH/1) | 0.03125 |
| A/duck/Guangxi/13/2004 (GX/13) | 0.06250 |
| A/crow/Osaka/102/2004 (OS/102) | 0.12500 |
| A/duck/Hong Kong/2986.1/2000 (HK/2986.1) | 0.06250 |
| A/goose/Guiyang/337/2006 (GY/337) | 0.25000 |
| A/duck/Guangxi/1378/2004 (GX/1378) | 0.06250 |
| A/duck/Hubei/wg/2002 (HB/wg) | 0.06250 |
| A/chicken/Vietnam/NCVD-016/2008 (VN/NCVD-016) | 0.03125 |
| A/chicken/Hong Kong/86.3/2002 (HK/86.3) | 0.06250 |
| A/chukar/Shantou/4690/2003 (ST/4690) | 0.25000 |
| A/Viet Nam/1203/2004 (VN/1203) K36T | 0.03125 |
| A/Viet Nam/1203/2004 (VN/1203) T263A | 0.06250 |
| A/Viet Nam/1203/2004 (VN/1203) L419I | 0.06250 |
The endpoint titer was defined as the lowest antibody concentration that gave an absorbance value of greater than 0.05 at 450 nm.
FIG 2Stem antibodies vary in binding to different H5 HAs. H5 HAs with different sensitivities to stem antibody neutralization were immunoprecipitated by the use of CR6261 (left) and C179 (right) and analyzed by Western blotting with H5 HA1 antiserum. Percentages of the HA1 signal intensities relative to the total input of each HA are indicated below each blot. Input, 1/8 of total sample used for IP; IP, immunoprecipitation; Control, IP negative control with anti HIV gp41 antibody (Chessie 8).
FIG 3H5 HAs have different conformational flexibilities that are associated with different sensitivities to stem antibody neutralization. (A and B) The levels of infectivity of H5 HA pseudoviruses were compared after they were treated for different lengths of time at 50°C (A) and for 1 h at different temperatures (B). Viral infectivity after treatment was normalized to the infectivity of untreated virus. (C) Cell-cell fusion levels mediated by different H5 HAs at various pHs were compared by fusion index. For the fusion index comparisons, the fusion levels of each HA-induced fusion at various pHs were normalized to the maximum level of each HA-induced fusion. (D) Stem antibody neutralization titers for H5 HA pseudoviruses were correlated with the pH value that is needed for 50% fusion induction (compared to maximum fusion). Data are shown as means and standard deviations of results from three experiments. Line colors in panels A, B, and C are coded by color as follows: red, high sensitivity to stem antibody neutralization; black, medium sensitivity; blue, low sensitivity. *, P < 0.05; **, P < 0.01.
FIG 4Stem antibody binding to HA is stable under a wide range of mildly acidic conditions (pH 4.7 to 7.0). CR6261 binding to HA coated on plates after treatment with pH 3.7 to 7.0 buffers was evaluated by ELISA. CR6261 binding to HA was normalized to the level of binding seen under conditions of pH 7.0 treatment. Data are shown as means and standard deviations of results from three experiments.
FIG 5Nonepitope residues affect HA flexibility and sensitivity to stem antibody neutralization. (A and B) The infectivities of wild-type VN/1203 and the corresponding mutant HA pseudoviruses were compared after they were treated for different times at 50°C (A) and for 1 h at different temperatures (B). HA pseudovirus infectivity after treatment was normalized to the infectivity of the corresponding untreated HA pseudovirus. (C) Cell-cell fusion levels mediated by VN/1203 and its mutant HA at various pHs were compared by fusion index. (D) Stem antibody neutralization titers for VN/1203 and the corresponding mutant HA pseudoviruses. Data are shown as means and standard deviations of results from three experiments. **, P < 0.01.